1e
19
1
49
2
2
18
1b
1d
18
32
3a
1d
2 29
1d
25
Yoseph Barash, Ph.D.
78
3a
Professor of Genetics
7
5f
Department: Genetics
4
1
23
1f
Graduate Group Affiliations
8
a
b
1d
46
Contact information
44
4
3
3
3
2
29
4
b
1f
44
Richards Building D205
35 3700 Hamilton Walk
Philadelphia, PA 19104
26
35 3700 Hamilton Walk
Philadelphia, PA 19104
2e
Office: 215-746-8683
32 Fax: 215-573-3111
24
83
32 Fax: 215-573-3111
24
Email:
yosephb@upenn.edu
12
yosephb@upenn.edu
13
Education:
21 a B.Sc. 29 (Computer Science and Physics) c
3e Hebrew University, Jerusalem, Israel., 1998.
21 a Ph.D. 34 (Machine learning, computational biology) c
66 School of Computer Science & Engineering Hebrew University, Jerusalem, Israel, 2006.
c
3
3
3
3
8d
Permanent link21 a B.Sc. 29 (Computer Science and Physics) c
3e Hebrew University, Jerusalem, Israel., 1998.
21 a Ph.D. 34 (Machine learning, computational biology) c
66 School of Computer Science & Engineering Hebrew University, Jerusalem, Israel, 2006.
c
2 29
21
1e
1d
24
76
de The lab develops machine learning algorithms that integrate high-throughput data (RNASeq, CLIPSeq , PIPSeq, etc.) to infer RNA biogenesis and function, followed by experimental verifications of inferred mechanisms.
8
11 Keywords:
ad Machine learning, probabilistic graphical models, computational biology, RNA splicing, post-transcriptional regulation, genomics, high-throughput sequencing analysis.
e 29
27
Description of Research Expertise
24 Research Interests:de The lab develops machine learning algorithms that integrate high-throughput data (RNASeq, CLIPSeq , PIPSeq, etc.) to infer RNA biogenesis and function, followed by experimental verifications of inferred mechanisms.
8
11 Keywords:
ad Machine learning, probabilistic graphical models, computational biology, RNA splicing, post-transcriptional regulation, genomics, high-throughput sequencing analysis.
e 29
23
11b Bergfort A, Gordon JM, Gazzara MR, Hung CT, Lee B, Barash Y, Neugebauer KM.: The exon junction complex coordinates the cotranscriptional inclusion of blocks of neighboring exons. Genes Dev 40: 94-109, Jan 2026.
13b Wang D, Gazzara MR, Jewell S, Wales-McGrath BD, Yang K, Brown CD, Choi PS, Barash Y.: A deep dive into statistical modeling of RNA splicing QTLs reveals variants that explain neurodegenerative disease. Am J Hum Genet 112: 3010-3029, Dec 2025.
161 Zhuang F, Gutman D, Islas N, Guzman BB, Jimenez A, Jewell S, Hand NJ, Nathanson K, Dominguez D, Barash Y.: G4mer: An RNA language model for transcriptome-wide identification of G-quadruplexes and disease variants from population-scale genetic data. Nat Commun 16: 10221, Nov 2025.
10c Gazzara MR, Cater T, Mallory MJ, Barash Y, Lynch KW.: Integrative analysis of RNA binding proteins identifies DDX55 as a novel regulator of 3'UTR isoform diversity. Genome Biol 26: 386, Nov 2025.
225 Sehgal P, Naqvi AS, Higgins M, Liu J, Harvey K, Jarroux J, Kim T, Mankaliye B, Mishra P, Watterson G, Fine J, Davis J, Hayer KE, Castro A, Mogbo A, Drummer C 4th, Martinez D, Koptyra MP, Ang Z, Wang K, Farrel A, Quesnel-Vallieres M, Barash Y, Spangler JB, Rokita JL, Resnick AC, Tilgner HU, De Raedt T, Powell DJ Jr, Thomas-Tikhonenko A.: NRCAM variant defined by microexon skipping is a targetable cell surface proteoform in high-grade gliomas. Cell Rep 44: 116099, Aug 2025.
157 Aicher JK, Issakova D, Slaff B, Jewell S, Lahens NF, Grant GR, Baralle D, Rosenfeld JA, Scott DA; Undiagnosed Diseases Network; Bhoj EJ, Barash Y.: MAJIQ-CLIN: A novel tool for the identification of Mendelian disease-causing variants from RNA-Seq data. medRxiv Feb 2025.
24a Sehgal P, Naqvi AS, Higgins M, Liu J, Harvey K, Jarroux J, Kim T, Mankaliye B, Mishra P, Watterson G, Fine J, Davis J, Hayer KE, Castro A, Mogbo A, Drummer C, Martinez D, Koptyra MP, Ang Z, Wang K, Farrel A, Quesnel-Vallieres M, Barash Y, Spangler JB, Rokita JL, Resnick AC, Tilgner HU, DeRaedt T, Powell DJ, Thomas-Tikhonenko A.: Neuronal cell adhesion molecule (NRCAM) variant defined by microexon skipping is an essential, antigenically distinct, and targetable proteoform in high-grade glioma. eLife Jan 2025.
12a Yang K, Islas N, Jewell S, Jha A, Radens CM, Pleiss JA, Lynch KW, Barash Y, Choi PS.: Machine learning-optimized targeted detection of alternative splicing. Nucleic Acids Res 53(3): gkae1260, Jan 2025 Notes: Co-corresponding.
fb Wu D, Maus N, Jha A, Yang K, Wales-McGrath BD, Jewell S, Tangiyan A, Choi P, Gardner JR, Barash Y.: Generative modeling for RNA splicing predictions and design. bioRxiv Jan 2025.
2c
7
1d
1f
Selected Publications
15f Yu S, Chen WC, Wang L, Jewell S, Mammedova A, Han SW, Wickramasinghe J, Barash Y, Tian B.: PolyA_DB v4: systematic polyA site identification and isoform annotation in human and mouse genomes using 3' end and long-read sequencing data. Nucleic Acids Res 54: D247-D254, Jan 2026.11b Bergfort A, Gordon JM, Gazzara MR, Hung CT, Lee B, Barash Y, Neugebauer KM.: The exon junction complex coordinates the cotranscriptional inclusion of blocks of neighboring exons. Genes Dev 40: 94-109, Jan 2026.
13b Wang D, Gazzara MR, Jewell S, Wales-McGrath BD, Yang K, Brown CD, Choi PS, Barash Y.: A deep dive into statistical modeling of RNA splicing QTLs reveals variants that explain neurodegenerative disease. Am J Hum Genet 112: 3010-3029, Dec 2025.
161 Zhuang F, Gutman D, Islas N, Guzman BB, Jimenez A, Jewell S, Hand NJ, Nathanson K, Dominguez D, Barash Y.: G4mer: An RNA language model for transcriptome-wide identification of G-quadruplexes and disease variants from population-scale genetic data. Nat Commun 16: 10221, Nov 2025.
10c Gazzara MR, Cater T, Mallory MJ, Barash Y, Lynch KW.: Integrative analysis of RNA binding proteins identifies DDX55 as a novel regulator of 3'UTR isoform diversity. Genome Biol 26: 386, Nov 2025.
225 Sehgal P, Naqvi AS, Higgins M, Liu J, Harvey K, Jarroux J, Kim T, Mankaliye B, Mishra P, Watterson G, Fine J, Davis J, Hayer KE, Castro A, Mogbo A, Drummer C 4th, Martinez D, Koptyra MP, Ang Z, Wang K, Farrel A, Quesnel-Vallieres M, Barash Y, Spangler JB, Rokita JL, Resnick AC, Tilgner HU, De Raedt T, Powell DJ Jr, Thomas-Tikhonenko A.: NRCAM variant defined by microexon skipping is a targetable cell surface proteoform in high-grade gliomas. Cell Rep 44: 116099, Aug 2025.
157 Aicher JK, Issakova D, Slaff B, Jewell S, Lahens NF, Grant GR, Baralle D, Rosenfeld JA, Scott DA; Undiagnosed Diseases Network; Bhoj EJ, Barash Y.: MAJIQ-CLIN: A novel tool for the identification of Mendelian disease-causing variants from RNA-Seq data. medRxiv Feb 2025.
24a Sehgal P, Naqvi AS, Higgins M, Liu J, Harvey K, Jarroux J, Kim T, Mankaliye B, Mishra P, Watterson G, Fine J, Davis J, Hayer KE, Castro A, Mogbo A, Drummer C, Martinez D, Koptyra MP, Ang Z, Wang K, Farrel A, Quesnel-Vallieres M, Barash Y, Spangler JB, Rokita JL, Resnick AC, Tilgner HU, DeRaedt T, Powell DJ, Thomas-Tikhonenko A.: Neuronal cell adhesion molecule (NRCAM) variant defined by microexon skipping is an essential, antigenically distinct, and targetable proteoform in high-grade glioma. eLife Jan 2025.
12a Yang K, Islas N, Jewell S, Jha A, Radens CM, Pleiss JA, Lynch KW, Barash Y, Choi PS.: Machine learning-optimized targeted detection of alternative splicing. Nucleic Acids Res 53(3): gkae1260, Jan 2025 Notes: Co-corresponding.
fb Wu D, Maus N, Jha A, Yang K, Wales-McGrath BD, Jewell S, Tangiyan A, Choi P, Gardner JR, Barash Y.: Generative modeling for RNA splicing predictions and design. bioRxiv Jan 2025.
2c